Immundiagnostik, Inc.

Immundiagnostik, Inc. is the North American subsidiary of Immundiagnostik AG, a clinical laboratory diagnostics company specializing in immunoassay-based detection solutions. The company develops and distributes ELISA kits and automated chemiluminescent analyzers for research and clinical laboratory applications across multiple therapeutic areas including cardiovascular and renal disease, bone and mineral metabolism, immunology, and complementary health. Their flagship product is the ECL100 Chemiluminescent Immunoassay Analyzer, a high-throughput automated platform for laboratory testing. The product portfolio includes specialized ELISA kits such as ox-LDL (oxidized low-density lipoprotein), 1,25-(OH)2 Vitamin D, EDN (endothelin), and HERO (Histamine Elimination Ratio) assays. Immundiagnostik serves clinical laboratories, research institutions, and healthcare facilities requiring sensitive and reliable biomarker detection. The company provides comprehensive support services including expert-guided assay validation assistance, custom bulk packaging solutions, technical support, and on-site training. They participate in major medical conferences (e.g., DDW 2026) and maintain a regional sales structure across North America with dedicated sales directors. The company is positioned as a supplier of both detection instrumentation and consumable assay kits for specialized laboratory diagnostics.